--- title: "Roth MKM Keeps Their Buy Rating on HEALWELL AI (AIDX)" type: "News" locale: "en" url: "https://longbridge.com/en/news/275806289.md" description: "Roth MKM analyst Kyle Bauser maintained a Buy rating on HEALWELL AI (AIDX) with a price target of C$2.50. Bauser has an average return of -12.4% and a 37.86% success rate, focusing on the Healthcare sector. Scotiabank's Kevin Krishnaratne also issued a Buy rating on February 4, while TipRanks reiterated a Hold rating on the same day." datetime: "2026-02-12T20:55:26.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/275806289.md) - [en](https://longbridge.com/en/news/275806289.md) - [zh-HK](https://longbridge.com/zh-HK/news/275806289.md) --- # Roth MKM Keeps Their Buy Rating on HEALWELL AI (AIDX) Roth MKM analyst Kyle Bauser reiterated a Buy rating on HEALWELL AI today and set a price target of C$2.50. ### Valentine's Day Sale - 70% Off - Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions - Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential According to TipRanks, Bauser is an analyst with an average return of \-12.4% and a 37.86% success rate. Bauser covers the Healthcare sector, focusing on stocks such as Electromed, HeartBeam, and Apyx Medical. In addition to Roth MKM, HEALWELL AI also received a Buy from Scotiabank’s Kevin Krishnaratne in a report issued on February 4. However, on the same day, TipRanks – Google reiterated a Hold rating on HEALWELL AI (TSX: AIDX). ### Related Stocks - [HAIWF.US](https://longbridge.com/en/quote/HAIWF.US.md) - [HAIAF.US](https://longbridge.com/en/quote/HAIAF.US.md) ## Related News & Research - [Healthcare AI Acquisition Secures New Short-Term Financing Note](https://longbridge.com/en/news/286132405.md) - [AI face is taking over — and driving plastic surgeons crazy](https://longbridge.com/en/news/286641783.md) - [How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here](https://longbridge.com/en/news/286786866.md) - [Virtuix Expands Into AI-Assisted Neurodivergent Therapy Through Rutgers University Collaboration | VTIX Stock News](https://longbridge.com/en/news/287075316.md) - [Neurovia AI CTO at ISNR: Solving the AI Data Cost Dilemma and Unleashing Infrastructure Capacity | AIIO Stock News](https://longbridge.com/en/news/287049307.md)